SEER Seer, Inc.
Healthcare$1.87+4.47%ClosedMarket Cap: $102.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.42
P/S
6.54
EV/EBITDA
-1.08
DCF Value
$-10.67
FCF Yield
-50.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.3%
Operating Margin
-496.4%
Net Margin
-468.7%
ROE
-26.6%
ROA
-25.9%
ROIC
-28.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.8M | 35.2% | $-17.3M | $-16.8M | $— | — |
| Q4 null | $4.1M | 50.5% | $-17.5M | $-16.0M | $— | — |
| FY null | $16.1M | 11.8% | $-78.5M | $-73.6M | $— | — |
| Q3 null | $4.1M | 51.2% | $-19.3M | $-18.2M | $— | — |
| Q2 null | $4.1M | 52.1% | $-20.5M | $-19.4M | $— | — |
| Q1 null | $4.2M | 49.0% | $-20.7M | $-19.9M | $— | — |
| Q4 null | $3.9M | 9.3% | $-23.5M | $-21.7M | $— | — |
| FY null | $13.9M | 49.0% | $-100.1M | $-86.6M | $— | — |
| Q3 null | $3.9M | 46.9% | $-24.3M | $-21.3M | $— | — |
| Q2 null | $3.1M | 7.5% | $-27.1M | $-22.9M | $— | — |
| Q1 null | $3.1M | -4.3% | $-25.2M | $-20.7M | $— | — |
| Q4 2023 | $4.2M | 41.7% | $-22.2M | $-17.8M | $-0.28 | — |